# Is Today&#8217;s Marijuana More Dangerous Than We Realize—Especially for Teens?

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/modern-cannabis-potency-risks-teens-young-adults/
> **Published:** 2026-03-10T17:02:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:09:35-04:00
> **Clinical Summary:** Explore modern cannabis potency risks and their impact on adolescent brain development, psychiatric symptoms, and cannabis use disorder.

---

✦ New

 CED Clinical Relevance
 #72
 Notable Clinical Interest
 Emerging findings or policy developments worth monitoring closely.

THCSafetyPediatricsMental HealthPolicy

 Why This Matters
 Clinicians need to understand that modern cannabis products contain significantly higher THC concentrations than historical street marijuana, which may increase risks of acute psychiatric symptoms, [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), and [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/), particularly in adolescents whose brains are still developing. Patients and parents should receive evidence-based counseling about these potency changes when discussing [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), as conventional risk information from past decades may underestimate current harms. Healthcare providers should screen for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns in teen and young adult patients and counsel against use during critical developmental windows when possible neurotoxic effects are greatest.

 Clinical Summary

This article raises [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) concerns about the changing potency and composition of modern cannabis products, particularly regarding their effects on adolescent neurodevelopment. Contemporary cannabis, especially concentrated forms like oils and edibles, typically contains significantly higher THC concentrations than historical cannabis, which may increase risks for [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), psychiatric symptoms, and [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) in young users whose brains are still developing. The advocacy perspective presented emphasizes that clinicians should be aware of these potency increases when counseling patients and families about cannabis risks, as the products available today differ substantially from those of previous decades. This distinction is particularly relevant for adolescent populations, where emerging evidence suggests greater vulnerability to adverse neuropsychiatric outcomes from high-potency products. Clinicians should incorporate information about modern cannabis potency into substance use screening and risk discussions with teenage patients and their parents, and consider referring high-risk youth to specialized addiction services when cannabis use is identified.

 Dr. Caplan’s Take
 “What we’re seeing in my practice is that the potency increase is real and clinically significant, but the greater concern isn’t potency per se—it’s that adolescents are using products their brains aren’t equipped to process safely, and we’re doing this experiment without proper informed consent or medical supervision. We need to stop pretending this is equivalent to the cannabis of thirty years ago while also resisting the urge to demonize the plant itself.”

 Clinical Perspective

While concerns about rising tetrahydrocannabinol (THC) potency in modern cannabis products are understandable, healthcare providers should recognize that Kevin Sabet’s advocacy organization has a clear policy agenda that may influence the framing of available evidence. The scientific literature does show associations between high-potency cannabis use and psychotic symptoms, particularly in adolescents whose brains are still developing, yet population-level data on cannabis-related harms have not uniformly escalated in proportion to reported potency increases, suggesting other factors—including frequency of use, route of administration, and individual vulnerability—substantially modify risk. When counseling patients and families, clinicians should acknowledge that [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) carries genuine neurobiological risks independent of potency, while avoiding overstated claims that cannot be fully substantiated by current epidemiologic data. A practical approach involves assessing individual risk factors (family history of psychosis, early use, heavy

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/)

Have thoughts on this? Share it:

 [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Is+Today%27s+Marijuana+More+Dangerous+Than+We+Realize%E2%80%94Especially+for+Teens%3F+%40drcaplan&url=https%3A%2F%2Fmichaelmedved.substack.com%2Fp%2Fis-todays-marijuana-more-dangerous)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fmichaelmedved.substack.com%2Fp%2Fis-todays-marijuana-more-dangerous)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Is+Today%27s+Marijuana+More+Dangerous+Than+We+Realize%E2%80%94Especially+for+Teens%3F+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fmichaelmedved.substack.com%2Fp%2Fis-todays-marijuana-more-dangerous)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)
 

 Related Articles

- [Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026](https://cedclinic.com/cannabis-and-cognitive-aging-2026-digest/)

📰 Source: [https://michaelmedved.substack.com/p/is-todays-marijuana-more-dangerous](https://michaelmedved.substack.com/p/is-todays-marijuana-more-dangerous)

CED Clinic Blog[Is Today’s Marijuana More Dangerous Than We Realize—Especially for Teens?](https://cedclinic.com/modern-cannabis-potency-risks-teens-young-adults/)
CED Clinic Blog[Teen who killed 6 in THC crash gets 65-year sentence – Arlington Today](https://cedclinic.com/teen-thc-crash-sentencing-legal-health-implications/)
CED Clinic Blog[Teens’ Self-Reported Cannabis Use Linked to Increased Risk for New Psychiatric Diagnosis](https://cedclinic.com/adolescent-cannabis-use-new-psychiatric-diagnoses-risk/)

Further Reading
CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/)
CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Cannabis affects childhood brain development, is 'real risk' for teens, UCSD finds in long-term study](https://cedclinic.com/cannabis-affects-childhood-brain-development-is-real-risk-for-teens-ucsd-finds-in-long-term-study/)

This long-term study from UCSD highlights the real risks cannabis poses to brain development in children and teens, emphasizing the importance of awareness and prevention.

[Learn More](https://cedclinic.com/cannabis-affects-childhood-brain-development-is-real-risk-for-teens-ucsd-finds-in-long-term-study/)

[Children's National Hospital sees more cannabis addiction among teens and tweens – WTOP News](https://cedclinic.com/adolescent-cannabis-addiction-risk-teens-tweens/)

An alarming rise in cannabis addiction among young populations is reported, underscoring the need for clinical vigilance and early intervention.

[Read the Report](https://cedclinic.com/adolescent-cannabis-addiction-risk-teens-tweens/)

[Doctor Sounds Alarm on Terrifying Studies Showing Real Impact of Marijuana Use – CBN](https://cedclinic.com/cannabis-harms-emerging-evidence-real-impact/)

A medical expert discusses recent studies revealing the significant impact of marijuana use, particularly focusing on mental health and adolescent risks.

[Explore Insights](https://cedclinic.com/cannabis-harms-emerging-evidence-real-impact/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
